Volume 120, Issue 5 , Pages 1023-1030, November 2007
Brief motivational interviewing as a clinical strategy to promote asthma medication adherence
Patient-centered approaches are associated with better patient retention and treatment outcomes, without increased time and cost. Motivational interviewing (MI) is a patient-centered counseling approach that can be briefly integrated into patient encounters and is specifically designed to enhance motivation to change among patients not ready to change. Existing asthma management approaches (eg, education and self-management) increase resistance among patients not ready or willing to follow medical recommendations. MI helps patients resolve their ambivalence about behavior change and builds their intrinsic motivation before providing education. Although MI overlaps with patient-centered communication, it additionally includes some concrete motivational strategies that can be briefly and easily implemented in medical settings (eg, setting an agenda, assessing motivation and confidence for change, helping the patient weigh the costs and benefits of change, and providing medical advice and health feedback). Reflective listening is used to help patients clarify their ambivalence and diffuse resistance. MI has been shown to be efficacious across a wide variety of health behavior change areas. This article will describe the method and spirit of MI as applied to asthma management by reviewing the principles of MI, brief MI strategies to motivate medication adherence, the evidence base for MI, and the costs and benefits of building MI into clinical practice.
Key words: Motivational interviewing, adherence, medication adherence, brief interventions, health behavior change, asthma management
Abbreviations used: HCP, Health care provider, ICS, Inhaled corticosteroid, MI, Motivational interviewing, OARS, Open-ended questions, affirmations, reflective listening, and summary statements
Supported in part by grants R01 HL062165-06 (BB) and HL079301 and HL075344 (KAR).
Disclosure of potential conflict of interest: B. Borrelli has consulting arrangements with and has received grant support from the National Institutes of Health. A. Weinstein has patent licensing arrangements with Asthma Management Systems and is employed by Asthma and Allergy Care. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(07)01583-7
doi:10.1016/j.jaci.2007.08.017
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 120, Issue 5 , Pages 1023-1030, November 2007
